Design and synthesis of simple macrocycles active against Vancomycin-resistant Enterococci (VRE)

Chemistry - A European Journal

Volumn 12, Issue 20, 2006, Pages 5334-5351

  Jia, Yanxing ^a   Ma, Nianchun ^a   Liu, Zuosheng ^a   Bois Choussy, Michèle ^a   Gonzalez Zamora, Eduardo ^b   Malabarba, Adriano ^c   Brunati, Cristina ^c   Zhu, Jieping ^a  

^a CNRS   (France)

^b DEPARTAMENTO DE QUÍMICA   (Mexico)

^c Italy Research Center   (Italy)

Author keywords

Antibiotics; Biaryl ether; Glycopeptides; Macrocycles; SNAr; Vancomycin

Indexed keywords

BIARYL ETHER; GLYCOPEPTIDES; MACROCYCLES; SNAR; VANCOMYCIN;

AMINO ACIDS; BINDING ENERGY; MICROSTRUCTURE; MOLECULAR DYNAMICS; PHASE TRANSITIONS; SUBSTITUTION REACTIONS;

OLEFINS;

AMIDE; ANTIINFECTIVE AGENT; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; HETEROCYCLIC COMPOUND;

ANTIBIOTIC RESISTANCE; ARTICLE; CHEMISTRY; DRUG DESIGN; DRUG EFFECT; ELECTROSPRAY MASS SPECTROMETRY; ENTEROCOCCUS; INFRARED SPECTROPHOTOMETRY; MICROBIOLOGICAL EXAMINATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STAPHYLOCOCCUS AUREUS; SYNTHESIS;

AMIDES; ANTI-BACTERIAL AGENTS; DRUG DESIGN; ENTEROCOCCUS; HETEROCYCLIC COMPOUNDS; INDICATORS AND REAGENTS; MAGNETIC RESONANCE SPECTROSCOPY; MICROBIAL SENSITIVITY TESTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROPHOTOMETRY, INFRARED; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANCE;

EID: 33745931661     PISSN: 09476539     EISSN: 15213765     Source Type: Journal    
DOI: 10.1002/chem.200600137     Document Type: Article

References (85)

1. For reviews see: a) D. H. Williams, Nat. Prod. Rep. 1996, 13, 469-477;
2. b) J. Zhu, Expert Opin. Ther. Pat. 1999, 9, 1005-1019;
3. c) K. C. Nicolaou, C. N. C. Boddy, S. Bräse, N. Winssinger, Angew. Chem. 1999, 111, 2230-2287;
4. Angew. Chem. Int. Ed. 1999, 38, 2096-2152;
5. d) R. D. Süssmuth, ChemBioChem 2002, 3, 295-298.
6. For reviews see: a) C. T. Walsh, S. L. Fisher, I.-S. Park, M. Prahalad, Z. Wu, Chem. Biol. 1996, 3, 21-28;
7. b) B. K. Hubbard, C. T. Walsh, Angew. Chem. 2003, 115, 752-789;
8. Angew. Chem. Int. Ed. 2003, 42, 730-765.
9. D.H. Williams, B. Bardsley, Angew. Chem. 1999, 111, 1264-1286;
10. Angew. Chem. Int. Ed. 1999, 38, 1172-1193.
11. R. K. Jain, J. Trias, J. A. Ellman, J. Am. Chem. Soc. 2003, 125, 8740-8741.
12. a) C. C. McComas, B. M. Crowley, D. L. Boger, J. Am. Chem. Soc. 2003, 125, 9314-9315;
13. b) J.-G. Lee, C. Sagui, C. Roland, J. Am. Chem. Soc. 2004, 126, 8384-8385.
14. Drugs Future 1997, 22, 1049-1050.
15. M. R. Barbachyn, C. W. Ford, Angew. Chem. 2003, 115, 2056-2070;
16. Angew. Chem. Int. Ed. 2003, 42, 2010-2023.
17. F. P. Tally, M. F. Debruin, J. Antimicrob. Chemother. 2000, 46, 523-526.
18. A. Malabarba, T. I. Nicas, R. C. Thompson, Med. Res. Rev. 1997, 17, 69-137.
19. R. Nagarajan, A. A. Schabel, J. L. Occolowitz, F. T. Counter, J. L. Ott, A. M. Felty-Duckworth, J. Antibiot. 1989, 42, 63-72.
20. D. Jabés, C. Candiani, G. Romano, C. Brunati, M. Riva, M. Cavaleri, Antimicrob. Agents Chemother. 2004, 48, 1118-1123.
21. D. Kahne, C. Leimkuhler, W. Lu, C. T. Walsh, Chem. Rev. 2005, 105, 425-448.
22. a) G. J. Sharman, A. C. Try, R. J. Dancer, Y. R. Cho, T. Staroske, B. Bardsley, A. J. Maguire, M. A. Cooper, D. P. O'Brien, D. H. Willimans, J. Am. Chem. Soc. 1997, 119, 12041-12047;
23. b) D. H. Williams, A. J. Maguire, W. Tsuzuki, M. S. Westwell, Science 1998, 280, 711 -714.
24. a) M. Ge, Z. Chen, H. R. Onishi, J. Kohler, L. L. Silver, R. Kerns, S. Fukuzawa, C. Thompson, D. Kahne, Science 1999, 284, 507-511;
25. b) U. S. Eggert, N. Ruiz, B. V. Falcone, A. A. Branstrom, R. C. Goldman, T. J. Silhavy, D. Kahne, Science 2001, 294, 361-364.
26. R. S. Roy, P. Yang, S. Kodali, Y. Xiong, R. M. Kim, P. R. Griffin, H. R. Onishi, J. Kohler, L. L. Silver, K. Chapman, Chem. Biol. 2001, 8, 1095-1106.
27. a) L. Chen, D. Walker, B. Sun, Y. Hu, S. Walker, D. Kahne, Proc. Natl. Acad. Sci. USA 2003, 100, 5658-5663;
28. b) C. Leimkuhler, L. Chen, D. Barrett, G. Panzone, B. Sun, B. Falcone, M. Oberthür, S. Donadio, S. Walker, D. Kahne, J. Am. Chem. Soc. 2005, 127, 3250-3251.
29. M. Bois-Choussy, L. Neuville, R. Beugelmans, J. Zhu, J. Org. Chem. 1996, 61, 9309-9322.
30. a) R. Xu, G. Greiveldinger, L. E. Marenus, A. Cooper, J. A. Ellman, J. Am. Chem. Soc. 1999, 121, 4898-4899;
31. b) K. A. Ahrendt, J. A. Olsen, M. Wakao, J. Trias, J. A. Ellman, Bioorg. Med. Chem. Lett. 2003, 13, 1683-1686.
32. a) C. J. Arnusch, R. J. Pieters, Eur. J. Org. Chem. 2003, 3131-3138;
33. for the synthesis of side-chain knotted bicyclic pentapeptide see: b) H. T. Ten Brink, D. T. S. Rijkers, J. Kemmink, H. W. Hilbers, R. M. J. Liskamp, Org. Biomol. Chem. 2004, 2, 2658-2663;
34. 4]vancomycin aglycon was reported see: c) B. M. Crowley, D. L. Boger, J. Am. Chem. Soc. 2006, 128, 2885-2892.
35. Total synthesis of vancomycin see: a) D. A. Evans, M. R. Wood, B. W. Trotter, T. I. Richardson, J. C. Barrow, J. L. Katz, Angew. Chem. 1998, 110, 2864-2868;
36. Angew. Chem. Int. Ed. 1998, 37, 2700-2704;
37. b) K. C. Nicolaou, M. Takayanagi, N. F. Jain, S. Natarajan, A. E. Koumbis, T. Bando, J. M. Ramanjulu, Angew. Chem. 1998, 110, 2881-2883;
38. Angew. Chem. Int. Ed. 1998, 37, 2717-2719;
39. c) D. L. Boger, S. Miyazaki, S. H. Kim, J. H. Wu, O. Loiseleur, S. L. Castle, J. Am. Chem. Soc. 1999, 121, 3226-3227;
40. total synthesis of teicoplanin see: d) D. L. Boger, S. H. Kim, S. Miyazaki, H. Strittmatter, J.-H. Weng, Y. Mori, O. Rogel, S. L. Castle, J. J. McAtee, J. Am. Chem. Soc. 2000, 122, 7416-7417;
41. e) D. A. Evans, J. L. Katz, G. S. Peterson, T. Hintermann, J. Am. Chem. Soc. 2001, 123, 12411-12413;
42. total synthesis of ristocetin aglycon see: B. M. Crowley, Y. Mori, C. C. McComas, D. Tang, D. L. Boger, J. Am. Chem. Soc. 2004, 126, 4310-4317.
43. For modification of vancomycin-type glycopeptide antibiotics by reprogramming the biosynthesis pathway see: a) S. Weist, C. Kittel, D. Bischoff, B. Bister, V. Pfeifer, G. J. Nicholson, W. Wohlleben, R. D. Süssmuth, J. Am. Chem. Soc. 2004, 126, 5942-5943;
44. b) D. Bischoff, B. Bister, M. Bertazzo, V. Pfeifer, E. Stegmann, G. J. Nicholson, S. Keller, S. Pelzer, W. Wohlleben, R. D. Süssmuth, ChemBioChem 2005, 6, 267-272, and references therein.
45. For selected examples of controlled degradation of glycopeptides see: a) A. Malabarba, R. Ciabatti, J. Med. Chem. 1994, 37, 2988-2990;
46. b) A. Malabarba, R. Ciabatti, J. Kettenring, P. Ferrari, K. Vékey, E. Bellasio, M. Denaro, J. Org. Chem. 1996, 61, 2137-2150;
47. c) A. Malabarba, R. Ciabatti, M. Maggini, P. Ferrari, L. Colombo, M. Denaro, J. Org. Chem. 1996, 61, 2151-2157;
48. d) A. Malabarba, R. Ciabatti, E. Gerli, F. Pipamont, P. Ferrari, L. Colombo, E. N. Olsufyeva, A. Y. Pavlov, M. I. Reznikova, E. I. Lazhko, M. N. Preobrazhenskaya, J. Antibiot. 1997, 50, 70-81;
49. e) A. Malabarba, T. I. Nicas, R. Ciabatti, Eur. J. Med. Chem. 1997, 32, 459-478;
50. f) A. Y. Pavlov, M. N. Preobrazhenskaya, A. Malabarba, R. Ciabatti, L. Colombo, J. Antibiot. 1998, 57, 73-78;
51. g) G. Panzone, P. Ferrari, M. Kurz, A. Trani, J. Antibiot. 1998, 51, 872-879;
52. h) S. S. Printsevskaya, A. Y. Pavlov, E. N. Olsufyeva, E. P. Mirchink, M. N. Preobrazhenskaya, J. Med. Chem. 2003, 46, 1204-1209, and references therein.
53. a) R. Kerns, S.D. Dong, S. Fukuzawa, J. Carbeck, J. Kohler, L. Silver, D. Kahne, J. Am. Chem. Soc. 2000, 122, 12608-12609;
54. b) Z. Chen, U. S. Eggert, S. D. Dong, S. J. Shaw, B. Sun, J. V. LaTour, D. Kahne, Tetrahedron 2002, 58, 6585-6594;
55. c) B. Sun, Z. Chen, U. S. Eggert, S. J. Shaw, J. V. LaTour, D. Kahne J. Am. Chem. Soc. 2001, 125, 12722-12723.
56. For reviews see reference [1c] and a) J. Zhu, Synlett 1997, 133-144;
57. b) J. S. Sawyer, Tetrahedron 2000, 56, 5045-5065.
58. Part of this work has been published as communications: a) N. Ma, Y. Jia, Z. Liu, E. Gonzalez-Zamora, M. Bois-Choussy, A. Malabarba, C. Brunati, J. Zhu, Bioorg. Med. Chem. Lett. 2005, 15, 743-746;
59. b) Y. Jia, E. Gonzalez-Zamora, N. Ma, Z. Liu, M. Bois-Choussy, A. Malabarba, C. Brunati, J. Zhu, Bioorg. Med. Chem. Lett. 2005, 15, 4594-4599.
60. C. Vergne, M. Bois-Choussy, J. Ouazzani, R. Beugelmans, J. Zhu, Tetrahedron: Asymmetry 1997, 8, 391-398.
61. Z. Liu, N. Ma, Y. Jia, M. Bois-Choussy, A. Malabarba, J. Zhu, J. Org. Chem. 2005, 70, 2847-2850.
62. For the definition of planar chirality see: E. L. Eliel, S. H. Wilen, Stereochemistry of Organic Compounds, Wiley, New York, 1994, Chapter 14.
63. For temperature-controlled atropdiastereoselective cycloetherification see: R. Beugelmans, M. Bois-Choussy, C. Vergne, J.-P. Bouillon, J. Zhu, Chem. Commun. 1996, 1029-1030.
64. For designed substrate-controlled atropdiastereoselective cycloetherification see: K. C. Nicolaou, C. N. C. Boddy, J. Am. Chem. Soc. 2002, 124, 10451-10455.
65. G. Islas-Gonzalez, M. Bois-Choussy, J. Zhu, Org. Biomol. Chem. 2003, 1, 30-32.
66. For X-ray structure see: P. J. Loll, A. E. Bevivino, B. D. Korty, P. H. Axelsen, J. Am. Chem. Soc. 1997, 119, 1516-1522.
67. Representative examples: a) U. N. Sundram, J. H. Griffin, T. I. Nicas, J. Am. Chem. Soc. 1996, 118, 13107-13108;
68. b) J. Rao, G. M. Whitesides, J. Am. Chem. Soc. 1997, 119, 10286-10290;
69. c) J. Rao, J. Lahiri, L. Isaacs, R. M. Weis, G. M. Whitesides, Science 1998, 280, 708-711;
70. d) T. Staroske, D.H. Williams, Tetrahedron Lett. 1998, 39, 4917-4920;
71. e) M. Adamczyk, J. A. Moore, S.D. Rege, Z. Yu, Bioorg. Med. Chem. Lett. 1999, 9, 2437-2440;
72. f) J. H. Griffin, M. S. Linsell, M. B. Nodwell, Q. Chen, J. L. Pace, K. L. Quast, K.M. Krause, L. Farrington, T. X. Wu, D. L. Higgins, T. E. Jenkins, B. G. Christensen, J. K. Judice, J. Am. Chem. Soc. 2003, 125, 6517-6531.
73. For a review on the polyvalent interaction in biological systems see: M. Mammen, S.-K. Choi, G. M. Whitesides, Angew. Chem. 1998, 110, 2908-2953;
74. Angew. Chem. Int. Ed. 1998, 37, 2754-2794.
75. P. Boullanger, J. Banoub, G. Descotes, Can. J. Chem. 1987, 65, 1343-1348.
76. R. R. Schmidt, Angew. Chem. 1986, 98, 213-236;
77. Angew. Chem. Int. Ed. Engl. 1986, 25, 212-235.
78. G. Islas-Gonzalez, J. Zhu, J. Org. Chem. 1999, 64, 914-924.
79. a) Y. Inouye, K. Onodera, S. Kitaoka, H. Ochiai, J. Am. Chem. Soc. 1957, 79, 4218-4222;
80. b) F. Micheel, H. Petersen, Chem. Ber. 1959, 92, 298-304;
81. c) H. M. Flowers, R. W. Jeanloz, J. Org. Chem. 1963, 28, 1564-1567.
82. Crysatallin 2-deoxy-2-trifluoroacetamido-α-D-glucopyranosyl bromide is an exception. The strong electron-withdrawing effect of the trifluoro acetyl function renders it more stable see: M. L. Wolfrom, H. B. Bhat, J. Org. Chem. 1967, 32, 1821-1823.
83. a) T. Temal-Laïb, J. Chastanet, J. Zhu, J. Am. Chem. Soc. 2002, 124, 583-590;
84. b) P. Cristau, T. Temal-Laïb, M. Bois-Choussy, M. T. Martin, J. P. Vors, J. Zhu, Chem. Eur. J. 2005, 11, 2668-2679, and references therein.
85. S. D. Dong, M. Oberthür, H. C. Losey, J. W. Anderson, U. S. Eggert, M. W. Peczuh, C. T. Walsh, D. Kahne, J. Am. Chem. Soc. 2002, 124, 9064-9065.